Tolfedine
The following is translated
from French to English by intern Tanya who
will be studying veterinary medicine in
2010. She learnt French in Secondary 3 and
was very helpful in the following
translation.
The literature for Tolfedine sold in
Singapore is in French. So, I get the
literature translated to share with vets
worldwide via the internet and with vet
undergraduates who wants to acquire more
knowledge to get the high distinctions.
There is an English translation of
Tolfedine from Vetoquinol on the internet
at:
Tolfedine is an NSAID (non-steroidal
anti-inflammatory drug), analgesic,
antipyretic for dogs, cats and cattle.
Some uses for tolfedine from the
manufacturer Vetoquinol are
compared to those recommended in the
British Small Animal Veterinary
Association (BSAVA)'s 2009 drug book. My
application of tolfedine as a pain-killer
post-neuter is illustrated for the benefit
of 4th-year veterinary students or those
who study veterinary pharmacology.
I
studied veterinary pharmacology in my 3rd
year at Glasgow University in 1969-1974
period. There were an overwhelming amount
of knowledge to learn and memorise and it
was quite boring as there was no internet
knowledge to read. The main Glasgow
University library in the early 1970s had
books that were outdated and brown with
age of a few hundred years. I hope the
following information may bring veterinary
pharmacology alive to the undergraduates
Active
ingredient: Tolfenamic acid
For
oral dosage:
6mg
Cats and
Small Dogs
20mg
Cats and
Dogs
60mg
Dogs
120mg
Dogs
Pharmacological
Properties
Tolfenamic acid
(N-(2-methyl-3-chlorophenyl)-acid
anthracitic) is a non-steroidal
anti-inflammatory drug (NSAID) of the
fenamate group. It has anti-inflammatory,
analgesic and antipyretic properties.
The
principles of its anti-inflammatory
properties are its inhibition of
cyclo-oxygenase leading to a reduction of
the synthesis of prostaglandins and
thromboxanes, important mediators of
inflammation.
In
dogs, tolfenamic acid is rapidly absorbed.
When one oral dose of 4mg/kg is
given, the average maximum plasma
concentration (CMax) of 4µg/ml is attained
in about one hour. Even when taking
tolfenamic acid during a meal, CMax is 2+3
µg/ml. The variations are due to important
entero-hepatic recycling of the molecule.
In
cats, the absorption of tolfenamic acid is
extremely rapid. When 1 oral dose of
4mg/kg is given, an average plasma
concentration (CMax) of 5.6µg/ml is
attained in about one hour (TMax).
Tolfenamic acid is distributed throughout
the organs of the body, with large
concentrations in the plasma, digestive
tract, liver, lungs and kidneys.
Contrarily, the concentration in the brain
is low. Tolfenamic acid and its
metabolites can cross the placental
barrier.
Tolfenamic acid is eliminated from the
body with a majority of the molecules
unchanged and a minority as inactive
metabolites.
In dogs
with renal disease (insufficient
function), the elimination of tolfenamic
acid is not modified.
Therapeutic indications
Dogs:
Treatment of symptoms of inflammation and
pain of osteo-articular and
musculo-skeletal disorders.
4mg/kg
of tolfenamic acid in single doses per
day. Either:
-
6mg
tablet for 1.5kg animals for up to three
days (with food)
-
20mg
tablet for 5kg animals for up to three
days (with food)
-
60mg
tablet for 15kg animals for up to three
days (with food)
-
120mg
tablet for 30kg animals for up to three
days (with food)
(BSAVA:
4 days. Repeated weekly dosing not
recommended in cats.)
Prescribe according to this table:
Product
Weight (kg)
Number of
Tablets
Tolfedine®
6mg Tablets for Cats and Dogs (up to
5kg)
1 – 2
1
2.5 – 3.5
2
Tolfedine®
20mg Tablets for Cats and Dogs (more
than 2.5kg)
3.5 – 5
˝ – 1
5 – 10
1 – 2
Tolfedine®
60mg Tablets for Dogs (more than 5kg)
7.5 – 15
˝ – 1
15 – 22.5
1 – 1 ˝
22.5 – 30
1 ˝ – 2
30-45
2 – 3
Tolfedine®
120mg Tablets for Dogs (more than
15kg)
15 – 30
˝ – 1
30-45
1 – 1 ˝
Dr Sing: One of my cases with
good feedback of the use of
tolfedine from the owner is at:
Contra-indications
The use
of tolfenamic acid is contra-indicated in
animals with cardiac or hepatic diseases.
Tolfenamic acid is also unsuitable for
animals with ulcers or bleeding in the
digestive tract, blood clotting problems (dyscrasia)
or hypersensitivity to tolfenamic acid. (BSAVA:
do not use on animals with blood clotting
problems. Animals with liver disease are
susceptible to overdosage due to prolonged
metabolism)
Special Precautions
-
The use
of tolfenamic acid presents special risks
when used in animals less than 6 weeks
old. If use is unavoidable, a reduced
dosage and clinical monitoring are
especially necessary.
-
Do not
exceed the recommended dose or duration.
-
Do not
use on animals with dehydration,
hypovolaemia, and/or hypotension
(possibility of increased risk of renal
toxicity)
-
Do not
give to animals under general anaesthesia.
-
Although tolfenamic acid can be given to
animals with chronic renal disease without
adjustment of dosage, tolfenamic acid
should not be given to animals with acute
renal failure.
-
In case
of undesirable side effects (anorexia,
vomiting, diarrhea, blood in feces)
occurring during the treatment, consult a
vet promptly.
Use
during Pregnancy and Lactation
Although laboratory studies showed no
effects of tolfenamic acid on
reproduction, use of tolfenamic acid
during gestation is inadvisable.
Drug
Interactions
Do not
give tolfenamic acid within 24 hours of
other NSAIDs. (BSAVA: glucocorticoids,
nephrotoxic agents). Tolfenamic acid
molecules strongly bind to plasma
proteins, competing with other NSAIDs.
In
dogs, administration of tolfenamic acid
for 3 consecutive days (BSAVA: 4
days) a week at 4mg/kg/day up to three
months is well tolerated. In case of
overdosage, administer symptomatic
treatment.
Side
effects
Diarrhea and vomiting occur rarely
during treatment. Also, a temporary
increase in thirst and/or urination may
occur. In most cases, these signs
disappear spontaneously upon cessation of
treatment. (Manufacturer: treatment can
continue) (BSAVA: Stop treatment if
effects last more than 1-2 days)
Particular Precautions for Elimination of
Unused Products/ Packaging
Empty
packaging/any remaining product should be
disposed of according to the rules on
waste disposal.
Tolfedine ® 4% Injectable Solution
Active
ingredient: Tolfenamic acid
Pharmacological Properties
Tolfenamic acid
(N-(2-methyl-3-chlorophenyl)-acid
anthracitic) is a non-steroidal
anti-inflammatory drug (NSAID) of the
fenamate group. It has
anti-inflammatory, analgesic and
antipyretic properties.
The
principles of its anti-inflammatory
properties are its inhibition of
cyclo-oxygenase leading to a reduction
of the synthesis of prostaglandins and
thromboxanes, important mediators of
inflammation.
In
dogs, tolfenamic acid is rapidly absorbed.
When injected, the average maximum plasma
concentration (CMax) of 4µm/ml
(subcutaneous) and 3µm/ml (intra-muscular)
is attained two hours after administration
of tolfenamic acid at 4mg/kg (IM and SC)
In
cats, the absorption of tolfenamic acid is
extremely rapid. After injection of 4mg/kg
of tolfenamic acid, the average maximum
plasma concentration (CMax) of 3.9µg/ml is
attained in approximately one hour (TMax)
Tolfenamic acid is distributed throughout
the organs of the body, with large
concentrations in the plasma, digestive
tract, liver, lungs and kidneys.
Contrarily, the concentration in the brain
is low. Tolfenamic acid and its
metabolites can cross the placental
barrier.
Tolfenamic acid is eliminated from the
body with a majority of the molecules
unchanged and a minority as inactive
metabolites.
In dogs
with renal disease (insufficient
function), the elimination of tolfenamic
acid is not modified.
Indications
Dogs:
Reduction of post-operative pain and
treatment of inflammation and pain due to
osteo-articular and musculo-skeletal
disorders
Cats:
Fever
Contra-Indications
The use
of tolfenamic acid is contra-indicated in
animals with cardiac or hepatic diseases.
Tolfenamic acid is also unsuitable for
animals with ulcers or bleeding in the
digestive tract, blood clotting problems (dyscrasia) or
hypersensitivity to tolfenamic acid.
Side
effects
Diarrhea and vomiting occur rarely during
treatment. Also, a temporary increase in
thirst and/or urination may occur. In most
cases, these signs disappear spontaneously
upon cessation of treatment.
Special Precautions
-
The use
of tolfenamic acid presents special risks
when used in animals less than 6 weeks
old. If use is unavoidable, a reduced
dosage and clinical monitoring are
especially necessary.
-
Do not
exceed the recommended dose or duration.
-
Do not
use on animals with dehydration,
hypovolaemia, and/or hypotension
(possibility of increased risk of renal
toxicity)
-
Do not
give to animals under general anaesthesia.
-
Although tolfenamic acid can be given to
animals with chronic renal disease without
adjustment of dosage, tolfenamic acid
should not be given to animals with acute
renal failure.
-
In case
of undesirable side effects (anorexia,
vomiting, diarrhea, blood in feces)
occurring during the treatment, consult a
vet promptly.
Precautions Particular to Persons
Administrating the Product to Animals
Observe
aseptic conditions for use of the
product.
Use
during Pregnancy and Lactation
Although laboratory studies showed no
effects of tolfenamic acid on
reproduction, use of tolfenamic acid
during gestation is inadvisable.
Drug
Interactions
Do not
give tolfenamic acid within 24 hours of
other NSAIDs. The tolfenamic acid
molecules strongly bind to plasma proteins
and will compete with the other NSAID
molecules.
Administration
Reduction of post-operative pain in dogs:
4mg/kg
tolfenamic acid is equivalent to 1
injection of 1ml/10kg (IM). As
premedication, it is preferably given 1
hour before anaesthesia.
Treatment of symptoms of inflammation and
pain due to osteo-articular and musculo-skeletal
disorders in dogs and fever in cats:
4mg/kg
of tolfenamic acid which is equivalent to
1 injection of 1ml/10kg (SC or IM,
subsequent doses given 48 hours apart) or
a single injected dose of 1ml/10kg
followed by oral administration. (Manufacturer:
oral treatment 24-48 hours after
injection, continued 3-5 days, 4mg/kg/day
in one dose)
In case
of overdosage, administer symptomatic
treatment.
Particular Caution for Special Animals
For
animals which have a low body weight, it
is recommended to use an insulin syringe
to administer a precise dose.
Precautions Pertaining to Conservation
After
opening, use within 28 days. Do not store
at temperatures above 25oC or
in bright light. Keep out of reach of
children.
Particular Precautions for Elimination of
Unused Products/ Packaging
Empty
packaging and any remaining product should
be disposed of according to the rules on
waste disposal.
P.S.
In my observations, tolfedine is effective
in relieving pain in most dogs and cats
after sterilisations. An injection is
given SC. The tablets are taken once a day
for 5 days at home. If no vomiting and if
the tablets are taken with food, there
should be good pain relief. I believe the
4mg/kg injection recommendation for SC
after surgery may not give good pain
relief in some dogs, from my
observations. This is equivalent to 1 ml
Tolfedine 4% per 10 kg bodyweight. In the
Cocker Spaniel at 9.3 kg, I gave slightly
more at 1.4 ml SC instead of around 1 ml.
There was pain relief for the next 24
hours. However, the owner gave the half of
60-mg tolfedine tablet at 7 am the next
day, on an empty stomach (dog did not in
the morning usually). The dog vomited
after 10 minutes. So, there was no
pain-relief on the 3rd day. The dog
started to traumatise its scrotal area
using the e-collar which was a specially
bigger size. Each dog is an
individual and so it is hard to generalise
on the dosage of injectable tolfedine
post-sterilisation.
For joint diseases, it is to be used 3 or
4 days per week, stop for 4 or 3 days and
repeat again for 3 months at a time
apparently. My associate vet use Rimadryl
as pain-relief after sterilisation. Each
vet has his own choices. Follow up
studies, recording of effects and
observations will be best in practice.
The above
translation is done for English-vets who may
have the French literature in their purchases.
References: BSAVA 2008th Edition's indications
compared to the manufactuer's